No significant changes in GATA3 or IL‐4 expression (Figure 7) indicate a limited impact on Th2 responses, consistent with the Th1/Th17‐driven pathology of SLE, where Th2 modulation is less critical (Dolff et al. 2011). Here, GATA3 is linked to systemic lupus erythematosus.